Innovative ways to promote insulin safety across University Hospital Southampton were showcased during a special visit to mark a national diabetes campaign.
Jessamy Baird, Country Lead and Head of General Medicines for Sanofi in the UK and Ireland, met with both the Trust’s CEO David French and Lead Inpatient Diabetes Specialist Nurse Paula Johnston on Friday, May 19, to mark Insulin Safety Week (ISW) 2023.
She met with the staff to discuss what activities were taking place at the hospital during ISW – a national campaign that raises awareness of insulin safety across care settings in the UK and Ireland.
On the visit, Jessamy watched the diabetes team at University Hospital Southampton spread the crucial insulin safety message in an engaging way with particular focus on the timings and types of insulin available.
Jessamy said: “I was delighted to meet the team at Southampton General Hospital today and witness the excellent activities they are carrying out to further awareness about insulin safety.
“Their dedication to their patients is really inspiring to see. At Sanofi, we’re proud to be a partner of this important initiative which helps to educate healthcare professionals to continue to improve care for people with diabetes.”
This year, ISW took place from Monday, May 15, to Sunday, May 21. The annual week-long campaign is designed to educate nurses, doctors and other healthcare staff about insulin and the need to understand the drug and use it safely.
Paula Johnston said: “Insulin Safety Week is a great initiative to remind clinical staff of their responsibilities around insulin prescribing and a great opportunity to highlight the support and training on offer to ensure clinicians can feel more confident in insulin administration.
“Here at University Hospital Southampton, we always like to support the Insulin Safety Week campaign as it gives us, as the inpatient diabetes team, the opportunity to go onto the wards to provide staff with information about insulin safety.”
ISW 2023 is organised by Orange Juice Communications, and Sanofi is the platinum programme partner. Sanofi have had no input into any arrangements or content.
For more information about ISW, visit www.insulinsafetyweek.com.